Back To Blog

#InTheSpotlight | Why government should provide more free HIV self-tests

Posted in: #InTheSpotlight, Access to Medicines, Focus, Healthcare system, HIV/AIDS, InFocus, Latest, Special Investigations, Spotlight

It is estimated that around half a million people living with HIV in South Africa don’t know they are living with the virus. One way to help these people is by offering them the means to test themselves in the privacy of their own homes. As Catherine Tomlinson explains in this #InTheSpotlight special briefing, such self-screening tests are part of our HIV response on paper, but in reality, the tests are massively underutilised.

Read More

#InTheSpotlight | Amid all the noise, how well is SA’s immunisation programme actually doing

Posted in: #InTheSpotlight, Focus, Healthcare system, InFocus, Latest, Spotlight

Childhood immunisation programmes have saved many millions of lives and prevented much suffering. Yet, immunisation programmes have lost momentum over the last decade or so. In this #InTheSpotlight special briefing, Elri Voigt unpacks the available data and considers how immunisation efforts might be revitalised.

Read More

For Professor Rachel Jewkes, blending research with activism is at the heart of her life’s work

Posted in: Access to Medicines, Focus, Healthcare system, Healthcare Workers, HIV/AIDS, InFocus, Latest, Spotlight

From anti-apartheid activist to top rated researcher, Professor Rachel Jewkes has spent her career trying to make the world a better place for women. Elri Voigt spoke to her about her journey to South Africa from the United Kingdom and how she became one of the country’s leading researchers on gender-based violence.

Read More

The current gonorrhoea meds might stop working – when will newer ones make it to SA?

Posted in: Access to Medicines, Focus, Healthcare system, Healthcare Workers, InFocus, Latest, Spotlight

Two new antibiotics offer hope for people with gonorrhoea that is resistant to currently available drugs. Yet, it might be years before the people who need these medicines can get them. Catherine Tomlinson unpacks why these new antibiotics are important and what needs to happen before they can be used in South Africa.

Read More

Competition law has again worked to fight a bad drug patent, but we need other solutions

Posted in: Access to Medicines, Focus, Healthcare system, HIV/AIDS, InFocus, Latest, Opinions, Spotlight, TB

A Competition Commission probe recently resulted in a patent on an important tuberculosis medicine being dropped in South Africa. Twenty years ago, a similar Competition Commission case resulted in a settlement that helped drive down the prices of several antiretrovirals, thereby helping to set the stage for the country’s HIV treatment programme. Fatima Hassan and Leena Menghaney connect the dots between the two landmark cases and map out what has and has not changed over the last two decades.

Read More

Integrating HIV and NCD care is critical but not straight-forward, clinicians say

Posted in: HIV/AIDS, Latest

With the remarkable success of antiretroviral treatment people living with HIV in South Africa are generally living much longer than they did two decades ago. As a result, more people with HIV are also now living with non-communicable diseases (NCDs) such as diabetes and hypertension. Accordingly, the need to better integrate HIV and NCD services was a hot topic at the recent Southern African HIV Clinicians Society conference in Cape Town. Elri Voigt reports.

Read More

Antibiotic slashes risk of drug-resistant TB in kids, finds major SA study

Posted in: Latest, TB, TB

Tuberculosis (TB) preventive therapy has been transformed in recent years, with treatment duration having been cut from six or more months to just three or one. Progress in developing new treatments to prevent drug-resistant forms of TB has however lagged behind, especially in children. Elri Voigt unpacks findings from a major new TB prevention study presented at the Union World Conference on Lung Health last week and plans for another important preventive therapy trial set to start soon.

Read More

1 2 3 … 6